Inc. - Articles and news items


Sucampo announces publication of NICE recommendation for AMITIZA® (Lubiprostone)

Industry news / 23 July 2014 / Sucampo Pharmaceuticals, Inc

Sucampo Pharmaceuticals, Inc. announced that the United Kingdom’s National Institute of Health and Care Excellence has published the technology appraisal guidance recommending the use of AMITIZA® (lubiprostone)…


Teva and OncoGenex announce top-line survival results of Phase III SYNERGY trial evaluating custirsen in combination with first-line docetaxel and prednisone for metastatic castrate-resistant prostate cancer

Industry news / 28 April 2014 / Teva

Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced results from the Phase III SYNERGY trial…

Amgen logo

Amgen and Watson announce collaboration to develop and commercialise oncology biosimilars

Industry news / 20 December 2011 / Amgen

Collaboration reflects the shared belief that the development will not follow a generic model…

Gilead logo

Gilead to make changes in hepatitis C drug trial design

Industry news, News / 5 September 2011 / Gilead Sciences, Inc.

Change does not affect ongoing “All Oral” clinical trials evaluating multiple direct-acting antivirals in combination…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...